85R7801 BEE-F     By: Thompson of Harris H.B. No. 1539       A BILL TO BE ENTITLED   AN ACT   relating to health benefit plan coverage of prescription drugs for   stage-four advanced, metastatic cancer.          BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:          SECTION 1.  Chapter 1369, Insurance Code, is amended by   adding Subchapter E-1 to read as follows:   SUBCHAPTER E-1. COVERAGE OF PRESCRIPTION DRUGS FOR STAGE-FOUR   ADVANCED, METASTATIC CANCER          Sec. 1369.211.  DEFINITION. In this subchapter, "stage-four   advanced, metastatic cancer" means cancer that has spread from the   primary or original site of the cancer to nearby tissues, lymph   nodes, or other areas or parts of the body.          Sec. 1369.212.  APPLICABILITY OF SUBCHAPTER. (a) This   subchapter applies only to a health benefit plan that provides   benefits for medical or surgical expenses incurred as a result of a   health condition, accident, or sickness, including an individual,   group, blanket, or franchise insurance policy or insurance   agreement, a group hospital service contract, or an individual or   group evidence of coverage or similar coverage document that is   issued by:                (1)  an insurance company;                (2)  a group hospital service corporation operating   under Chapter 842;                (3)  a health maintenance organization operating under   Chapter 843;                (4)  an approved nonprofit health corporation that   holds a certificate of authority under Chapter 844;                (5)  a multiple employer welfare arrangement that holds   a certificate of authority under Chapter 846;                (6)  a stipulated premium company operating under   Chapter 884;                (7)  a fraternal benefit society operating under   Chapter 885;                (8)  a Lloyd's plan operating under Chapter 941; or                (9)  an exchange operating under Chapter 942.          (b)  Notwithstanding any other law, this subchapter applies   to:                (1)  a small employer health benefit plan subject to   Chapter 1501, including coverage provided through a health group   cooperative under Subchapter B of that chapter;                (2)  a standard health benefit plan issued under   Chapter 1507;                (3)  a basic coverage plan under Chapter 1551;                (4)  a basic plan under Chapter 1575;                (5)  a primary care coverage plan under Chapter 1579;                (6)  a plan providing basic coverage under Chapter   1601;                (7)  health benefits provided by or through a church   benefits board under Subchapter I, Chapter 22, Business   Organizations Code;                (8)  group health coverage made available by a school   district in accordance with Section 22.004, Education Code;                (9)  the state Medicaid program, including the Medicaid   managed care program operated under Chapter 533, Government Code;                (10)  the child health plan program under Chapter 62,   Health and Safety Code;                (11)  a regional or local health care program operated   under Section 75.104, Health and Safety Code;                (12)  a self-funded health benefit plan sponsored by a   professional employer organization under Chapter 91, Labor Code;                (13)  county employee group health benefits provided   under Chapter 157, Local Government Code; and                (14)  health and accident coverage provided by a risk   pool created under Chapter 172, Local Government Code.          (c)  This subchapter applies to coverage under a group health   benefit plan provided to a resident of this state regardless of   whether the group policy, agreement, or contract is delivered,   issued for delivery, or renewed in this state.          Sec. 1369.213.  PROHIBITED CONDUCT. (a) A health benefit   plan that provides coverage for stage-four advanced, metastatic   cancer may not require, before the health benefit plan provides   coverage of a prescription drug approved by the United States Food   and Drug Administration, that the enrollee:                (1)  fail to successfully respond to a different drug;   or                (2)  prove a history of failure of a different drug.          (b)  This section applies only to a drug the use of which is:                (1)  consistent with best practices for the treatment   of stage-four advanced, metastatic cancer; and                (2)  supported by peer-reviewed medical literature.          SECTION 2.  This Act applies only to a health benefit plan   delivered, issued for delivery, or renewed on or after January 1,   2018. A health benefit plan delivered, issued for delivery, or   renewed before January 1, 2018, is governed by the law as it existed   immediately before the effective date of this Act, and that law is   continued in effect for that purpose.          SECTION 3.  This Act takes effect September 1, 2017.